These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 20541334)
1. Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals. Kortekaas J; Ketelaar J; Vloet RP; Loeffen WL Vet Microbiol; 2011 Jan; 147(1-2):11-8. PubMed ID: 20541334 [TBL] [Abstract][Full Text] [Related]
2. Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals. Kortekaas J; Vloet RP; Weerdmeester K; Ketelaar J; van Eijk M; Loeffen WL J Virol Methods; 2010 Feb; 163(2):175-85. PubMed ID: 19770004 [TBL] [Abstract][Full Text] [Related]
3. The double-antigen ELISA concept for early detection of E Meyer D; Fritsche S; Luo Y; Engemann C; Blome S; Beyerbach M; Chang CY; Qiu HJ; Becher P; Postel A Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921 [TBL] [Abstract][Full Text] [Related]
4. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif. von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779 [TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals. Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003 [TBL] [Abstract][Full Text] [Related]
6. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies. Aebischer A; Müller M; Hofmann MA Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022 [TBL] [Abstract][Full Text] [Related]
8. Vaccinology of classical swine fever: from lab to field. van Oirschot JT Vet Microbiol; 2003 Nov; 96(4):367-84. PubMed ID: 14599784 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus. Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain. Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn Schröder C; Dräger C; Aebischer A; Dähnert L; Breidenstein C; Mamerow S; Leidenberger S; Beer M; Blome S Vet Microbiol; 2016 Nov; 196():14-17. PubMed ID: 27939149 [TBL] [Abstract][Full Text] [Related]
12. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge. Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400 [TBL] [Abstract][Full Text] [Related]
13. Development of a marker vaccine candidate against classical swine fever based on the live attenuated vaccine C-strain. Han Y; Xie L; Yuan M; Ma Y; Sun H; Sun Y; Li Y; Qiu HJ Vet Microbiol; 2020 Aug; 247():108741. PubMed ID: 32768202 [TBL] [Abstract][Full Text] [Related]
14. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. Wehrle F; Renzullo S; Faust A; Beer M; Kaden V; Hofmann MA J Gen Virol; 2007 Aug; 88(Pt 8):2247-2258. PubMed ID: 17622629 [TBL] [Abstract][Full Text] [Related]
15. Reduced specificity of E Meyer D; Loeffen W; Postel A; Fritsche S; Becher P Transbound Emerg Dis; 2018 Apr; 65(2):e505-e508. PubMed ID: 29314759 [TBL] [Abstract][Full Text] [Related]
16. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response. Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope. Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497 [TBL] [Abstract][Full Text] [Related]
18. Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever. Laughlin RC; Madera R; Peres Y; Berquist BR; Wang L; Buist S; Burakova Y; Palle S; Chung CJ; Rasmussen MV; Martel E; Brake DA; Neilan JG; Lawhon SD; Adams LG; Shi J; Marcel S Plant Biotechnol J; 2019 Feb; 17(2):410-420. PubMed ID: 29993179 [TBL] [Abstract][Full Text] [Related]
19. The challenges of classical swine fever control: modified live and E2 subunit vaccines. Huang YL; Deng MC; Wang FI; Huang CC; Chang CY Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of classical swine fever virus antibody detection assays with an emphasis on the differentiation of infected from vaccinated animals. Schroeder S; von Rosen T; Blome S; Loeffen W; Haegeman A; Koenen F; Uttenthal A Rev Sci Tech; 2012 Dec; 31(3):997-1010. PubMed ID: 23520753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]